15-(tert-Butoxy)-15-oxopentadecanoic acid

Catalog No. :
ACWLME961
CAS No. :
905302-42-3
Molecular Formula :
C19H36O4
Molecular Weight :
328.49

IUPAC Name:15-(tert-butoxy)-15-oxopentadecanoic acid

15-(tert-Butoxy)-15-oxopentadecanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g99%$104.00Login to see priceIn stockIn stock
100g99%$406.00Login to see priceIn stockIn stock
500g99%$1198.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name15-(tert-Butoxy)-15-oxopentadecanoic acid
IUPAC Name15-(tert-butoxy)-15-oxopentadecanoic acid
MDL No.MFCD30470973
Molecular FormulaC19H36O4
Molecular Weight328.49
SMILESO=C(CCCCCCCCCCCCCC(=O)OC(C)(C)C)O
InChI KeyBDHAQLJDYZFGNC-UHFFFAOYSA-N
SynonymPentadecanedioic acid mono-t-butyl ester;Pentadecanedioic acid, 1-(1,1-dimethylethyl) ester;Pentadecanedioic acid mono-tert-butyl ester;Pentadecanedioic acid 1-tert-butyl ester;15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecanoic acid
CAS No.905302-42-3
PubChem CID87125741

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWLME961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACCOKV369 route compound structure diagram
    ACCOKV3691460-18-0 In Stock
  4. Then
  5. ACWLME961 route product structure diagram
    ACWLME961905302-42-3 In Stock
Inquiry

2. ACWLME961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOKV369 route compound structure diagram
    ACCOKV3691460-18-0 In Stock
  4. Then
  5. ACWLME961 route product structure diagram
    ACWLME961905302-42-3 In Stock
Inquiry

Comments (0)